Document Detail


Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis.
MedLine Citation:
PMID:  7473486     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To investigate the outcome of children with juvenile rheumatoid arthritis (JRA) who discontinued taking methotrexate (MTX) therapy after the achievement of clinical remission. METHODS: We conducted a retrospective review of the clinical course of all consecutive patients with JRA treated with MTX at our department. RESULTS: Seventeen of the 30 patients who responded to treatment entered clinical remission 6 to 30 mo after beginning MTX therapy. All patients were discontinued from MTX within 2 to 5 mo. Five patients relapsed within 9 mo, whereas 12 patients had sustained remission for 12 mo or longer. Four of 5 children with extended pauciarticular JRA relapsed early after MTX discontinuation. These patients were less responsive to a further cycle of MTX, and 3 showed progression of radiographic joint lesions. CONCLUSION: These findings suggest that MTX should be continued in patients with extended pauciarticular JRA even after the achievement of clinical remission.
Authors:
A Ravelli; S Viola; B Ramenghi; L Aramini; N Ruperto; A Martini
Related Documents :
12492246 - Patients' views of priority setting for new medicines. a qualitative study of patients ...
2562786 - Gold-naproxen pneumonitis. a toxic drug interaction?
9817866 - Rubella virus and chronic joint disease: is there an association?
20535786 - Neutropenia in patients receiving anti-tumor necrosis factor therapy.
9773796 - Mortality in end-stage renal disease is associated with facility-to-facility difference...
2660576 - The association between decreased amniotic fluid volume and treatment with nonsteroidal...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of rheumatology     Volume:  22     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1995-12-12     Completed Date:  1995-12-12     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  1574-6     Citation Subset:  IM    
Affiliation:
Clinica Pediatrica dell'Universit?, Istituto di Ricovero e Cura a Carattere Scientifico S. Matteo, Pavia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Antirheumatic Agents / administration & dosage,  therapeutic use*
Arthritis, Juvenile Rheumatoid / drug therapy*
Child
Child, Preschool
Female
Humans
Infant
Male
Methotrexate / administration & dosage,  therapeutic use*
Recurrence
Remission Induction
Retrospective Studies
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antirheumatic Agents; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of food on the bioavailability of oral methotrexate in children.
Next Document:  Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antib...